Full-Time
Senior Financial Analyst
Hospice
Posted on 9/16/2025
BrightSpring Health Services
10,001+ employees
Home-based and community health services, pharmacy
No salary listed
Louisville, KY, USA
In Person
 Finance & Banking (1) |
|---|
- Bachelor's degree in Finance, Accounting or Data Science
- Three to five years of relevant experience
- Knowledge, Skills and Abilities: Ability to use complex reporting processes, systems, and report writing tools
- Knowledge, Skills and Abilities: High attention to detail, timeliness, and accuracy
- Knowledge, Skills and Abilities: Experience in budgeting, and forecasting
- Knowledge, Skills and Abilities: Experience with development of variance and trend financial analysis
- Knowledge, Skills and Abilities: Highly proficient in the Microsoft Office Suite applications (Excel and Powerpoint); experience with Oracle ERP, Power BI and Workday/Adaptive FP&A software a plus
- Knowledge, Skills and Abilities: Strong analytical and communication skills
- Knowledge, Skills and Abilities: Ability to effectively and professionally communicate (verbal and written) with all levels of personnel both internal and external to the company
- Knowledge, Skills and Abilities: Knowledge of current industry trends, standards, and practices
- The Senior Financial Analyst will serve as a major finance contributor over an assigned region and/or business line, will be a key partner to operational leaders by helping to define, and drive all financial analysis and reporting for their assigned business. The successful candidate will be seen as a driver of results within the business, across disciplines (census growth, revenue rate, labor management, cost model optimization, billing collections and capital expenditures)
- Drive Business Performance: More than reporting the numbers, the Sr. Financial Analyst is responsible for monitoring key performance metrics and recommending action to improve operational performance across many areas. Specifically:o Modeling of each agency's financials - Model the optimal financial performance for each agency, monitor performance against the model/benchmarks, so that leaders can drive change at the field level where gaps existo Monthly Core Cost tracking and control - On a weekly and monthly basis, monitor material operating model expenses and deliver insights on where and how to improve. Supports company efforts to drive an environment of fiscal management across every level of the organization and ensure all agencies have the information needed to remain in line with approved operating plans and budgetso Labor Management – On a weekly and monthly basis, review staff model, contract labor, productivity, and worked hours compared to planned hours to identify areas where staffing needs to be addressed
- Accounting Close Support - Review key revenue and expense activity and accruals during month end close in order to identify issues and work with accounting team to correct before numbers are finalized
- Standardized Reporting - To support their businesses, ensure all reporting is produced timely and provides valuable information to understand current business trends, and utilizes reporting to identify focus areas - addressing with operations and other functions as needed.
- Forecast – Develop projections, driven by key operational metrics analyzed in partnership with operations partners, and present forecast to senior leadership regularly. Provide flash updates on metrics and corresponding revenue and EBITDA each monthly review cycle
- Budget - Create annual operational budgets for each site/location within the assigned business, assessing run rates, growth plans, staffing needs/requests, and regulatory impacts. Present budgets to leadership within operating segment and to Sr. Leadership
- Ad hoc analysis / projects - As a valuable resource to a business unit, various analytical initiatives will be assigned. These include rate/volume variance analyses, wage increase valuation, proforma development for new business, union negotiation analysis and other operational reporting projects that may arise
- CPA/CFA or MBA preferred
BrightSpring Health Services provides home and community-based health care through two main operations: Pharmacy and Provider. In Pharmacy, it offers services for patients with complex and chronic conditions, including specialty, infusion, and community pharmacy solutions. In Provider, it delivers home health, behavioral health, hospice care, and services for intellectual and developmental disabilities. The company uses an integrated care model that connects pharmacy services with in-home care across its network to support patients, families, and managed care organizations. Revenue comes from reimbursed services paid by Medicare, Medicaid, and private insurers. Its goal is to coordinate ongoing, in-home and community-based care across a continuum—from pharmacy support to direct care—ensuring coordinated, patient-centered services for individuals with complex or chronic needs.
Company Size
10,001+
Company Stage
Post IPO Equity
Headquarters
Louisville, Kentucky
Founded
1974
Simplify's Take
What believers are saying
- Q1 2026 revenue hit $3.61B, up 26%, raising full-year guidance to $14.98B.
- Amedisys and LHC acquisitions add 107 locations, contributing $30M EBITDA in 2026.
- Sevita sale yields $811M cash for debt reduction and $2B M&A through 2028.
What critics are saying
- Money Message ransomware stole 2M records including SSNs in March 2023 breach.
- DOJ fined ResCare in October 2019 for fake Medicaid revaluations from 2009-2014.
- Pomerantz investigates securities fraud by BrightSpring officers as of 2026.
What makes BrightSpring Health Services unique
- BrightSpring integrates specialty pharmacy with home health for complex chronic care patients.
- PharMerica dispenses 40 million prescriptions annually to 4 million patients.
- Provider services target intellectual disabilities via home-based behavioral health.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Flexible Work Hours
Company News
BrightSpring Health Services announced the resignation of Robert Barnes as President of ResCare Community Living on 30 March 2026, stating it was not due to any disagreement over operations or policies. The company's shares rose 5.2% following upbeat analyst reports from its investor day. Management unveiled ambitious long-term organic EBITDA growth targets of 15% to 20% annually through 2028, alongside AI-driven efficiency plans for its home and community-based care platform. The narrative projects $16.8 billion in revenue and $361.8 million in earnings by 2028, requiring 10.1% yearly revenue growth. Investors remain focused on whether BrightSpring can balance acquisition-driven expansion and technology investment whilst managing its substantial debt load and regulatory exposure.
BrightSpring Health Services has seen its stock price surge 43.1% over the past six months to $42.32 per share, driven by strong quarterly results. The healthcare services company, founded in 1974, offers home health care, hospice, neuro-rehabilitation and pharmacy services. BrightSpring's revenue grew at an 18.3% compound annual growth rate over the past five years, outpacing the healthcare sector average. Analysts forecast 15% revenue growth over the next 12 months, though this represents a deceleration from its recent 20.9% annual rate. However, the company's five-year average return on invested capital of 4.9% falls below the typical cost of capital for healthcare firms, suggesting historically mediocre capital efficiency. The stock currently trades at 27.7× forward price-to-earnings ratio.
BrightSpring Health Services has raised questions about its valuation after trading at 24.5 times forward earnings following strong 2025 performance. The company reported fourth-quarter revenue of $3.55 billion, up 29.3% year-over-year, with adjusted EBITDA rising 40.7% to $184 million. For 2026, management guided revenue between $14.45 billion and $15 billion, representing 11.9% to 16.2% growth, whilst adjusted EBITDA is expected to grow faster at 23% to 28%, indicating margin expansion. However, the company faces approximately $600 million in revenue headwinds from Inflation Reduction Act impacts and brand-to-generic conversions. The valuation hinges on whether BrightSpring can deliver sequential profitability improvements throughout the year despite policy and product-mix pressures affecting headline revenue growth.
BrightSpring Health Services led senior health stocks in Q4 earnings, reporting revenues of $3.55 billion, up 16.3% year on year and beating analyst expectations by 5%. The company delivered strong full-year EBITDA guidance. In contrast, Chemed posted the weakest performance, with revenues of $639.3 million falling 3% short of expectations. The company missed both revenue and full-year EPS guidance estimates, sending shares down 19.2% to $377.07. The seven senior health, home health and hospice stocks tracked reported slower Q4 results overall, with revenues beating consensus estimates by just 1.1%. Share prices have declined an average of 9.6% since earnings releases. The sector faces headwinds from labour shortages and wage inflation whilst benefiting from an ageing population and growing preference for in-home care.
BrightSpring Health Services outlined its growth strategy at an investor day, highlighting a shift towards core home-and-community clinical services. The company's planned community-living divestiture will close soon to boost cash flow and support integrated care initiatives. BrightSpring reported significant deleveraging from approximately 4.5x post-IPO to 2.99x (2.6x pro forma), with leverage expected to fall below 2x in 2026. The company reiterated 2026 guidance of $14.45–$15.0 billion revenue and $760–$790 million adjusted EBITDA, whilst targeting 15–20% organic adjusted EBITDA compound annual growth for 2026–2028. The healthcare services provider has at least $2 billion available for acquisitions through 2028. Its operations include dispensing over 40 million prescriptions annually through PharMerica, serving more than 4 million patients, with recent branch integrations expected to add approximately $30 million of EBITDA.